Latest newsLATEST NEWS

We aim to become one of the leading pharmaceutical companies and to do all in our power to help prevent infectious diseases.

2023/03/08
MVC quadrivalent flu vaccine received the NDA approval letter
see more
2022/08/02
The National University of Asunción's Team Shared Phase III Study Data of MVC COVID-19 Vaccine
see more
2022/06/09
Medigen Vaccine Biologics reports positive results from 200-dose bag for mass vaccination of COVID-19 vaccines
see more
2022/06/05
Medigen Vaccine Biologics Completed Enrollment for First-in-Human study of Next-generation COVID-19 Vaccine, and Published Animal Challenge Data in International Journal
see more
2022/05/13
Additional Update on Clinical Development on Medigen's MVC-COV1901 in the COVID-19 Solidarity Trial Vaccines
see more
2022/03/02
BlueWillow Biologics and Medigen Vaccine Biologics Announce Positive Results for Intranasal COVID-19 Booster Candidate in Pre-clinical Studies
see more
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies. Our Privacy & Cookie Policy contains more information on such use and explains how to disable cookies.
Agree